2.4 mg Semaglutide in Units: Reading Your Wegovy Dose

What decision are you actually trying to make about this dose?

People searching for 2.4 mg semaglutide in units are usually in one of a few situations. Some have received a prescription or clinical letter that lists the dose in micrograms rather than milligrams and want to check they match. Others are comparing different injectable GLP-1 products (where dosing conventions vary) and need a like-for-like figure to anchor the comparison. A smaller group are transitioning from insulin-pen use, where doses have historically been counted in international units, and the terminology has crossed over into weight-loss conversations online.

The conversion itself is simple: 1 mg equals 1,000 micrograms, so 2.4 mg semaglutide is 2,400 micrograms, often written as 2,400 mcg or, in some clinical shorthand, 2,400 units of micrograms. If you are looking at a volume figure instead, the Wegovy pen delivers 2.4 mg in 0.68 ml, a figure set by the manufacturer, cited in the Mounjaro and Wegovy SmPCs on the eMC, and not something you need to calculate yourself. The pen does not have gradations. You press, it delivers.

Knowing which question you are really asking makes it easier to find the right answer. The sections below work through each scenario in turn.

How 2.4 mg fits into the full semaglutide dose ladder

Reaching 2.4 mg is a journey, not a starting point. Wegovy's titration schedule begins at 0.25 mg and increases roughly every four weeks: 0.25 mg, then 0.5 mg, then 1 mg, then 1.7 mg, and finally 2.4 mg as the standard maintenance dose. Your prescriber decides when each step is appropriate based on how you are tolerating the treatment, not on a fixed calendar. Some people spend longer at an intermediate dose; others move through more quickly. In unit terms, that means the dose climbs from 250 mcg at the start to 2,400 mcg at full maintenance, a roughly tenfold increase across the schedule. A fuller breakdown of the whole range is covered on the Wegovy doses page if you want to see all five steps side by side.

The clinical rationale for this gradual climb is nausea reduction. Semaglutide slows gastric emptying and reduces appetite, both of which the gut needs time to adjust to. Starting low gives the body that adjustment period. The NHS medicines information on semaglutide, published at nhs.uk, confirms this schedule and describes the common side effects associated with each stage, mostly gastrointestinal, generally settling within a few weeks of a new dose.

One practical note: the MHRA approved a higher 7.2 mg maintenance dose in January 2026, and the dedicated single-dose 7.2 mg pen followed in April 2026. If you have seen references to this, it is a development above the 2.4 mg ceiling that applied at launch. The 2.4 mg figure remains clinically significant as the standard endpoint for most patients on the original titration pathway.

When the unit question comes up most often, and how to handle it

The phrase "units" causes genuine confusion in this context because it is used loosely. In insulin therapy, one unit is a precisely defined international standard. In semaglutide prescribing, "units" is not an official term at all, doses are written in milligrams or micrograms, and the pen handles volume internally. So if you have seen "2.4 mg semaglutide in units" on a forum or in a clinical handout, the most likely reading is that it refers to micrograms: 2,400 of them.

Where this becomes practically important is for people converting between products or trying to understand a clinical document from a different setting. If you are moving from one semaglutide format to another (say, exploring whether the Wegovy injection is right for you versus a different approach) the mg figure is the one that travels across product types cleanly. Volume and pen markings differ by manufacturer and formulation. Common points of confusion include working out how many mg 20 units of semaglutide represents, or understanding what 10 units of semaglutide works out to in mg, both of which the relevant pages explain in full. For a broader look at how unit and mg figures relate across the semaglutide dose range, the semaglutide dose in units page covers the full conversion picture.

If there is any discrepancy between what your prescription says and what you expected, the right move is to contact your prescribing team before injecting. That is not an overreaction; it is the correct use of the clinical support that comes with a properly supervised prescription. At nume, that support is available seven days a week. Questions about what you have been prescribed (or concerns about a dose you received from another provider) are exactly what our prescribers are there for.

What this means for choosing a treatment route

If you are researching 2.4 mg semaglutide because you are considering starting Wegovy, the dose conversion is background knowledge rather than the deciding factor. What actually shapes suitability is clinical assessment: your BMI, any weight-related conditions, your medication history, and how your body is likely to respond to a GLP-1 medicine. A number on a page does not substitute for that conversation.

For context on what the research shows at this dose, the STEP 1 trial (published in the New England Journal of Medicine) reported an average body-weight reduction of around 15% over 68 weeks in adults with obesity taking 2.4 mg semaglutide weekly alongside lifestyle changes. That figure comes from a controlled trial; individual results vary, and a prescriber is best placed to discuss what realistic outcomes look like for you. You can read more about treatment options and eligibility on the weight-loss overview page, or look at how private treatment works on the buy Wegovy online page.

One thing worth knowing about the physical reality of treatment: when the pen arrives, it comes in a plain, unbranded box via DPD with a tracking notification on your phone. The pen itself is compact and pre-set. There is no measuring, no unit counting at the point of injection. The dose conversion matters at the prescription stage; by the time the pen is in your hand, it is already done.

If you are ready to find out whether Wegovy is clinically appropriate for you, the next step is a free consultation. Check your eligibility and one of our GPhC-registered prescribers will review your answers the same day.